Distigmine Bromide

溴地斯的明

Report date: 2024/05/09 14:16:00
NME

Base Information

Drug NameDistigmine Bromide
Drug Alias Namebromuro de distigmina溴化双吡己胺bromure de distigminedistigmini bromidumUbretid +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsDysuriaGlaucomaEsotropia +[4] 
Global Approved IndicationsDysuriaMyasthenia Gravis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1967/09/05
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTorii Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTorii Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDysuriaGlaucomaEsotropia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN07AA03
Related LinksWikipediaKEGG